Study title: Double-blind Pediatric Study to Assess the Safety, Pharmacokinetics and Efficacy of Single IV Doses of Palonosetron, 3.0 μg/kg or 10.0 μg/kg, in the Prevention of Chemotherapy- Induced Nausea and Vomiting
Type of medicine: Centrally authorised medicines | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: PALONOSETRON HYDROCHLORIDE | |||||
ATC code: A04AA05 | |||||
Document link: | |||||
Document date: 2011-11-09 | |||||
Study number: Palo-99-07 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
Y | Y | Y | Y | Y |